Vitality Watch

Dossier clinicaltrials observational 09-nov-2026
Human cohort, case-control, or epidemiological association

Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI

Key claim: Sarcopenia and muscle loss represent critical prognostic factors that warrant systematic screening in chronic heart failure and pre-TAVI patients to guide management.

Abstract

The main objective was to assess the prevalence of sarcopenia in chronic heart failure patients and in patients before the trans aortic valvular implantation.

The loss of muscle mass in chronic heart failure patients is a prognostic factor for sarcopenia. The purpose was to identify in these patients signs of sarcopenia for a better management.

Why this matters

Sarcopenia and muscle loss represent critical prognostic factors that warrant systematic screening in chronic heart failure and pre-TAVI patients to guide management.

Source

Link

Briefing card

Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI
Stage: observational · clinicaltrials · 09-nov-2026

Sarcopenia and muscle loss represent critical prognostic factors that warrant systematic screening in chronic heart failure and pre-TAVI patients to guide management.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT03153774

build build 880 · 2bcef25 · 2026-11-18